Faculty
Faculty in this T32 program have been selected among members of the Cancer Biology and Genetics and the Molecular and Cellular Biosciences clusters of the Biomedical Sciences Graduate Program with affiliations at the Fels Cancer Institute for Personalized Medicine, Fox Chase Cancer Center and various departments within the Lewis Katz School of Medicine. Faculty selection has been guided by strong teaching/mentoring record of graduate students and/or postdoctoral fellows commensurate with academic rank, research interests broadly related to the program theme and extramural funding history. We have also ensured a broad range of research approaches and model systems, collaborative spirit, and faculty diversity.
FCCC = Fox Chase Cancer Center
CBGN = Cancer Biology and Genetics
MCBS = Molecular and Cellular Biosciences
Igor Astsaturov, MD, PhD
Cancer signaling and cholesterol metabolism, pancreatic cancer
CBGN/FCCC
Siddharth Balachandran, PhD
Cell Death Pathways in Innate Immunity
MCBS/FCCC
Jonathan Chernoff, MD, PhD
Oncogenic signal transduction
CBGN/FCCC
Israel Cañadas, PhD
Tumor immunity and the tumor microenvironment in lung cancer
CBGN/FCCC
Margie L. Clapper, PhD
Biomarkers of cancer risk, early detection and targeted chemopreventive intervention
CBGN/FCCC
Edna Cukierman, MsC, PhD
Effects of tumor-associated fibroblasts and ECMs in assorted epithelial cancers
CBGN/FCCC
Roland Dunbrack, PhD
Structural bioinformatics and computational biology; protein design
MCBS/FCCC
James Duncan, PhD
Kinase biology and drug resistance
CBGN/FCCC
John Elrod, PhD
Mitochondrial biology, calcium signaling, metabolism, heart failure, neurodegeneration
MCBS
Nora I. Engel, PhD
Imprinting Disorders in Cancer
CBGN
Joan Font-Burgada, PhD
Tissue dynamics and Cancer initiation
CBGN/FCCC
Silvia Fossati, PhD
Molecular mechanisms of cell death/stress underlying the causes of neurodegeneration
MCBS
Ana M. Gamero, PhD
STAT2, a signaling component of type I interferons: role in cancer and inflammation
CBGN
Glenn S. Gerhard, MD
Genomics of Complex Disorders
MCBS
Erica A. Golemis, PhD
Analyzing and targeting cancer signaling networks
CBGN/FCCC
Xavier Graña, PhD
Cell cycle regulation and cell signaling via phosphorylation
CBGN
Jean-Pierre J. Issa, MD
Epigenetics
CBGN
Neil Johnson, PhD
Cancer Biology
CBGN
Dietmar Kappes, PhD
Normal and malignant hematopoiesis
FCCC
John Karanicolas, PhD
Computational and chemical biology
MCBS/FCCC
Walter J. Koch, PhD
GPCR Signaling
MCBS
Jeffrey R. Peterson, PhD
Cancer cell signaling and metabolism
MCBS/FCCC
Swayam Prabha, MBA, PhD
Developmental Therapeutics/Cell based cancer therapies
CBGN/FCCC
Lori Rink, PhD
Resistance to targeted agents in GIST
CBGN/FCCC
Brad S. Rothberg, PhD
Structural biology and pharmacology of ion channel proteins
MCBS
Carmen Sapienza, PhD
Genetics/Epigenetics, Gene/Environment Interaction
CBGN
Bassel E. Sawaya, PhD
HIV-1 and Neuronal Degeneration
MCBS
Tomasz Skorski, MD, PhD, DSc
Targeting DNA repair to induce synthetic lethality, personalized medicine, intracellular signaling pathways
CBGN
Nathaniel W. Snyder, PhD, MPH, DABT
Metabolism, exposures, and health outcomes
MCBS
Jonathan Soboloff, PhD
Calcium signaling
MCBS
Ying Tian, PhD
Cell proliferation and differentiation signaling
MCBS
Douglas Tilley, PhD
GPCR signaling in the heart and immune cells
MCBS
Kelly A. Whelan, PhD
Mechanisms of esophageal homeostasis
CBGN
Johnathan R. Whetstine, PhD
Understanding how the chromatin microenvironment regulates gene expression while maintaining a stable genome.
CBGN/FCCC
David Wiest, PhD
Normal and malignant hematopoiesis
CBGN/FCCC
Ling Yang, PhD
Role of lncRNA in metabolic disorders
MCBS
Zeng-jie Yang, MD, PhD
Tumor Microenvrionment and Cancer Stem cells
CBGN/FCCC
M. Raza Zaidi, PhD
Pathobiology of UV-induced melanomagenesis
CBGN